MRC NEWSLETTER

Meeting with met Mr. Haruo Naito Representative Corporate Officer and CEO, Eisai Co., Ltd, Yokohama, Japan, 2019.

Eisai2

During the Tokyo International Conference on African Development (TICAD) VII which was organised in Yokohama, in the period 28th - 30th August, 2019, Professor Ahmed Fahal, Director, Mycetoma Research Centre, University of Khartoum, WHO collaborating Centre on Mycetoma had met Mr.

Haruo Naito Representative Corporate Officer and CEO, Eisai Co., Ltd which is the leading Japanese pharmaceutical company. They had discussed the close collaboration with the two institutions. Prof Fahal thanked him and Eisai for supporting the first ever double blind clinical trial on mycetoma treatment currently been conducted at the MRC, Khartoum, Sudan.  

Eisai1